Thaddeus A. Tomaszek

3.4k total citations
40 papers, 2.2k citations indexed

About

Thaddeus A. Tomaszek is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Thaddeus A. Tomaszek has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Infectious Diseases and 12 papers in Virology. Recurrent topics in Thaddeus A. Tomaszek's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Bone Metabolism and Diseases (11 papers). Thaddeus A. Tomaszek is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Bone Metabolism and Diseases (11 papers). Thaddeus A. Tomaszek collaborates with scholars based in United States and United Kingdom. Thaddeus A. Tomaszek's co-authors include Thomas D. Meek, Scott K. Thompson, Thomas J. Carr, Geoffrey B. Dreyer, Maxine Gowen, Mark A. Levy, Mary J. Bossard, Fred H. Drake, Michael L. Moore and Daniel F. Veber and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Thaddeus A. Tomaszek

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thaddeus A. Tomaszek United States	23	1.4k	687	594	535	469	40	2.2k
Chih‐Tai Leu United States	17	1.1k 0.8×	883 1.3×	816 1.4×	454 0.8×	348 0.7×	25	2.2k
Yu Ru China	11	671 0.5×	220 0.3×	167 0.3×	191 0.4×	293 0.6×	24	1.1k
Lorenzo M. Leoni United States	30	1.8k 1.3×	258 0.4×	350 0.6×	817 1.5×	352 0.8×	57	3.7k
Zucai Suo United States	34	3.5k 2.6×	604 0.9×	358 0.6×	216 0.4×	82 0.2×	125	4.1k
Riccardo Gavioli Italy	31	1.1k 0.8×	232 0.3×	496 0.8×	937 1.8×	315 0.7×	119	3.1k
Mary H. Hanlon United States	17	925 0.7×	283 0.4×	210 0.4×	448 0.8×	105 0.2×	27	1.3k
Paul R. Sleath United States	16	1.2k 0.9×	243 0.4×	293 0.5×	571 1.1×	117 0.2×	22	3.5k
Edelmira Cabezas United States	12	1.1k 0.8×	80 0.1×	212 0.4×	114 0.2×	148 0.3×	13	1.7k
Tsui-Ling Hsu Taiwan	36	2.9k 2.1×	140 0.2×	94 0.2×	509 1.0×	1.2k 2.5×	64	4.0k
Andrew J. Lucke Australia	22	1.1k 0.8×	103 0.1×	34 0.1×	184 0.3×	378 0.8×	36	1.7k

Countries citing papers authored by Thaddeus A. Tomaszek

Since Specialization

Citations

This map shows the geographic impact of Thaddeus A. Tomaszek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thaddeus A. Tomaszek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thaddeus A. Tomaszek more than expected).

Fields of papers citing papers by Thaddeus A. Tomaszek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thaddeus A. Tomaszek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thaddeus A. Tomaszek. The network helps show where Thaddeus A. Tomaszek may publish in the future.

Co-authorship network of co-authors of Thaddeus A. Tomaszek

This figure shows the co-authorship network connecting the top 25 collaborators of Thaddeus A. Tomaszek. A scholar is included among the top collaborators of Thaddeus A. Tomaszek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thaddeus A. Tomaszek. Thaddeus A. Tomaszek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kerns, Jeffrey K., Hong Nie, William E. Bondinell, et al.. (2011). Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituent. Bioorganic & Medicinal Chemistry Letters. 21(15). 4409–4415. 10 indexed citations

Kumar, Sanjay, Lauren Dare, Janice A. Vasko-Moser, et al.. (2006). A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone. 40(1). 122–131. 104 indexed citations

Haffner, Curt D., Darryl McDougald, Brian Thompson, et al.. (2005). 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV. Bioorganic & Medicinal Chemistry Letters. 15(23). 5257–5261. 20 indexed citations

Yamashita, Dennis S., Hong Lin, Binghe Wang, et al.. (2004). Benzodioxocin‐3‐ones and N‐acyl‐3‐amino‐3‐buten‐2‐ones: novel classes of cathepsin K cysteine protease inhibitors^*. Journal of Peptide Research. 63(3). 265–269. 3 indexed citations

Marquis, Robert W., Keith W. Ward, Theresa J. Roethke, et al.. (2003). An Azepanone-Based Inhibitor of Human Cathepsin K with Improved Oral Bioavailability in the Rat and the Monkey. Molecular Pharmaceutics. 1(1). 97–100. 6 indexed citations

James, Ian E., Robert W. Marquis, Simon Blake, et al.. (2001). Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in Vitro. Journal of Biological Chemistry. 276(15). 11507–11511. 28 indexed citations

Duffy, Kevin J., Lance H. Ridgers, Renée L. DesJarlais, et al.. (1999). Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K. Bioorganic & Medicinal Chemistry Letters. 9(14). 1907–1910. 12 indexed citations

Thompson, Scott K., Ward W. Smith, Baoguang Zhao, et al.. (1998). Structure-Based Design of Cathepsin K Inhibitors Containing a Benzyloxy-Substituted Benzoyl Peptidomimetic. Journal of Medicinal Chemistry. 41(21). 3923–3927. 17 indexed citations

DesJarlais, Renée L., Dennis S. Yamashita, Hye-Ja Oh, et al.. (1998). Use of X-ray Co-crystal Structures and Molecular Modeling To Design Potent and Selective Non-peptide Inhibitors of Cathepsin K. Journal of the American Chemical Society. 120(35). 9114–9115. 32 indexed citations

10.

Towler, Eric M., Scott K. Thompson, Thaddeus A. Tomaszek, & Christine Debouck. (1997). Identification of a Loop Outside the Active Site Cavity of the Human Immunodeficiency Virus Proteases Which Confers Inhibitor Specificity. Biochemistry. 36(17). 5128–5133. 9 indexed citations

11.

Bossard, Mary J., Thaddeus A. Tomaszek, Scott K. Thompson, et al.. (1996). Proteolytic Activity of Human Osteoclast Cathepsin K. Journal of Biological Chemistry. 271(21). 12517–12524. 404 indexed citations

12.

NEWLANDER, K. A., James F. Callahan, M. Lane Moore, Thaddeus A. Tomaszek, & William F. Huffman. (1993). A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of .gamma.-turn mimetics into a model substrate. Journal of Medicinal Chemistry. 36(16). 2321–2331. 35 indexed citations

13.

Dreyer, Geoffrey B., Jeffrey C. Boehm, Balan Chenera, et al.. (1993). A symmetric inhibitor binds HIV-1 protease asymmetrically. Biochemistry. 32(3). 937–947. 58 indexed citations

14.

Dreyer, Geoffrey B., Dennis M. Lambert, Thomas D. Meek, et al.. (1992). Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, x-ray crystallography, and infected T-cell assays. Biochemistry. 31(29). 6646–6659. 110 indexed citations

15.

Tomaszek, Thaddeus A., Michael L. Moore, James E. Strickler, et al.. (1992). Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease. Biochemistry. 31(42). 10153–10168. 35 indexed citations

16.

Deckman, Ingrid C., Michael D. Minnich, Jeffrey S. Culp, et al.. (1991). Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. Biochemistry. 30(34). 8424–8434. 42 indexed citations

17.

Tomaszek, Thaddeus A., Gerald D. Roberts, Steven A. Carr, et al.. (1991). Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by oxygen-18 isotope exchange. Biochemistry. 30(34). 8441–8453. 93 indexed citations

18.

Tomaszek, Thaddeus A., et al.. (1991). Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. Biochemistry. 30(34). 8454–8463. 199 indexed citations

19.

Meek, Thomas D., Dennis M. Lambert, Geoffrey B. Dreyer, et al.. (1990). Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature. 343(6253). 90–92. 201 indexed citations

20.

Bossard, Mary J., Thaddeus A. Tomaszek, Brian W. Metcalf, & Jerry L. Adams. (1989). A novel, convenient assay of lanosterol 14α-demethylase. Bioorganic Chemistry. 17(4). 385–399. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact